S&P 500 7,674.48 −1.07%
Nasdaq 26,157.61 −2.04%
S&P/TSX 35,943.02 −1.05%
Apple 345.71 +0.50%
Nvidia 213.46 −3.83%
Microsoft 526.19 −1.27%
Shopify 239.84 −2.08%
Royal Bank 282.81 −0.29%
CAD/USD 0.7131 +0.31%
LIVE · 12:05 ET
Market ClerkRecap
Thu Oct 22 · markets open6 signals today108 insider buys this week · $250.3MCIRO short report next: Oct 31The week ahead

NBIX

NEUROCRINE BIOSCIENCES INC
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
141.96
+0.65 +0.46%
USD · close Oct 22

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $14.4BP/E 20.8DIV YIELD —FCF YIELD 6.03%REV TTM $3.4B +34.4%NET INCOME $705.5M +102.6%NET CASH —52W 123.10 – 185.50SEC XBRL · TTM TO Invalid Date

Congress is trading it

STOCK ACT DISCLOSURES
No STOCK Act disclosure names NBIX.

The STOCK Act allows 45 days to disclose; a lag over that is shown in red. Amounts are the ranges members report. Every member, every trade.

Watch NBIX. Know when insiders buy.
One email the day a filing lands. Free.